Noleus Technologies: Accelerating Recovery After Abdominal Surgery | MTW North America 2026
Why It Matters
Accelerating bowel recovery could slash hospital stays and complications, delivering billions in savings while improving postoperative care for millions of patients.
Key Takeaways
- •Abdominal surgery patients face 3‑10 day hospital stays due to gut paralysis
- •Nollis Leaf uses negative pressure to jump‑start bowel function
- •First‑in‑human trial showed bowel recovery two days faster
- •Device costs under $300 at scale, saving hospitals ~$3,000 per case
- •Company seeks $1.4M to fund 10‑15 patient efficacy study
Summary
At the MTW North America 2026 showcase, Nollis Technologies unveiled the Nollis Leaf, a novel internal negative‑pressure device designed to restore intestinal motility immediately after abdominal surgery.
The company highlighted that 2.9 million U.S. patients undergo major abdominal procedures annually, with 15‑20% experiencing postoperative ileus that extends hospital stays by 3‑10 days. In a first‑in‑human study, the Leaf reduced time to bowel function by roughly two days, promising to cut complications and accelerate discharge.
CEO Dr. Swarna Balasubramanyam explained that the Leaf repurposes low‑risk, class‑II wound‑care negative‑pressure technology into a $300‑at‑scale implant, compared with current hospital costs of about $3,000 per day. The firm is pursuing a 510(k) pathway leveraging existing devices and aims to secure reimbursement codes.
If the upcoming 10‑15‑patient trial confirms efficacy, the Leaf could generate significant savings for hospitals, improve patient outcomes, and position Nollis for a lucrative exit, echoing the $250‑$420 million valuations of its prior FDA‑cleared products.
Comments
Want to join the conversation?
Loading comments...